CYP19A1 and cancer: During this time they learn how to evaluate and manage numerous cancer specific disorders including neoplasm related fatigue, trismus, comprehensive care for metastatic spinal disease, chemotherapy induced neuropathy, aromatase inhibitor arthralgias, cancer related cognitive impairment, radiation fibrosis syndrome, post-mastectomy pain syndrome, survivorship issues, neurologic complications secondary to checkpoint inhibitors, musculoskeletal graft vs. host disease and several others.